116
PERGUNTAS & RESPOSTAS
RETINOPATIA DIABÉTICA - Novo Paradigma de Cuidados
proliferative diabetic retinopathy (IBeHi study), Acta Ophthalmologica
2008; 86(4):385–9.
19.
Yeh PT, Yang CM, Lin YC, Chen MS, Yang CH, Bevacizumab pretreatment
in vitrectomy with silicone oil for severe diabetic retinopathy,” Retina
2009;29(6):768–74.
20.
Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R, Intravitreal bevacizu-
mab for prevention of early postvitrectomy hemorrhage in diabetic patients a
randomized clínical trial, Ophthalmology 2009;116(10):1943–8.
21.
Rizzo S, Genovesi-Ebert F, Bartolo E, Vento A, Miniaci S, Williams G,
Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct
before vitrectomy surgery in the treatment of severe proliferative diabetic
retinopathy (PDR), Graefe’s Arch Clini Exp Ophthalmol 2008;246(6):837–
842.
22.
Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L et al., Trac-
tional retinal detachment following intravitreal bevacizumab (Avastin)
in patients with severe proliferative diabetic retinopathy, Br J Opthalmol
2008;92(2):213–6.
23.
González VH, Giuliari GP, Banda RM, Guel DA. Intravitreal injection of
pegaptanib sodium for proliferative diabetic retinopathy, Br J Opthalmol
2009;93(11):1474–8.
24.
Comparison of Age-related Macular Degeneration Treatments Trials
(
CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe
GJ et al. Ranibizumab and bevacizumab for treatment of neovascular
age-related macular degeneration: two-year results, Ophthalmology
2012;119(7):1388-98.
25.
IVAN Study Group, Chakravarthy U, Harding SP, Rogers CA, Downes SM,
Lotery AJ, et al. Ranibizumab versus bevacizumab to treat neovascular
age-related macular degeneration: one-year findings from the IVAN ran-
domized trial, Ophthalmology 2012;119(7):1399-411.
26.
Bandello F, Cunha-Vaz J, Chong NV, Lang GE, Massin P, Mitchell P et al.
New approaches for the treatment of diabetic macular oedema: recom-
mendations by an expert panel. Eye (Lond) 2012;26(4):485-93.